-
Product Insights
Violet Mine
The Violet Mine is a gold mine in Russia. It is currently in operation. Empower your strategies with our Violet Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Gain vital information...
-
Product Insights
Violet Capital – Kevlar Gardens Residential Complex – Florida
Equip yourself with the essential tools needed to make informed and profitable decisions with our Violet Capital - Kevlar Gardens Residential Complex - Florida report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
Access Ind/ Hines Interests – 2045 Violet Street Office Tower – California
Equip yourself with the essential tools needed to make informed and profitable decisions with our Access Ind/ Hines Interests - 2045 Violet Street Office Tower - California report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Product Insights
Onni Group – 2143 E. Violet Street Mixed-Use Development – California
Equip yourself with the essential tools needed to make informed and profitable decisions with our Onni Group - 2143 E. Violet Street Mixed-Use Development - California report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Product Insights
Quarterly Chocolate pricing trends in Hong Kong
Consumers' preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important business choices. GlobalData's new report titled "Quarterly Chocolate pricing trends in Hong Kong" serves as a crucial resource for analyzing...
-
Product Insights
Quarterly Chocolate pricing trends in Singapore
Consumers' preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important business choices. GlobalData's new report titled "Quarterly Chocolate pricing trends in Singapore" serves as a crucial resource for analyzing pricing...
-
Company Profile
Hoya Corp – Company Profile
Hoya Corp (Hoya) is a med-tech company, which manufactures and sells precision devices and instruments built on its advanced optics technologies. Its principal products include eyeglasses and contact lenses, laparoscopic surgical instruments, medical endoscopes, intraocular lenses, orthopedic implants, airway scopes, blanks/photomasks for semiconductors, photomasks for liquid crystal display (LCD) panel, and glass disk for hard disk drives (HDDs); and imaging products such as optical lenses/glass, camera lens modules, plastic lenses, laser equipment and ultra violet (UV) light sources. It also...
Add to Basket -
Product Insights
Quarterly Sugar Confectionery pricing trends in the United Kingdom
Consumers' preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important business choices. GlobalData's new report titled "Quarterly Sugar Confectionery pricing trends in the United Kingdom" serves as a crucial resource...
-
Product Insights
Net Present Value Model: Remsima/Inflectra
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Remsima/Inflectra Drug Details Infliximab biosimilar (Remsima,...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – infliximab biosimilar
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry infliximab biosimilar Drug Details Infliximab biosimilar (Remsima, Inflectra, Flixceli, Emisima, Remsima SC, Infliximab BS,...